Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/1993
11/09/1993US5260205 Anion exchange medium, elution
11/09/1993US5260203 Computer based system determined chemical structure for converting two naturally aggregated but chemically separated light and heavy polpeptide chain into single chain having three dimensional structure
11/09/1993US5259951 Passing solution of Factor VIII from human plasma through ion exchange chromatographic column using as equilibrating buffer and eluent high ionic strength saline solution at acid pH; stabilizers
11/09/1993US5259939 Dynamic buffer coating
11/09/1993CA1324095C Recombinant ricin toxin
11/08/1993CA2095588A1 Synthetic lipid a glycoconjugate antigens for use in vaccines
11/07/1993CA2095577A1 Purification of plasminogen activator inhibitor 2 by immunoaffinity chromatography
11/03/1993EP0568178A1 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
11/03/1993EP0567567A1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
11/03/1993EP0477198B1 Method for recovering recombinant proteins
11/03/1993EP0374182B1 Biospecific polymers
11/03/1993EP0368864B1 Whey protein fractions
11/03/1993CN1077961A Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
11/03/1993CN1077960A Hemoregulatory peptides
11/02/1993US5258545 Amino acid derivative, method for preparing the same and method for preparing human osteocalcin using the same
11/02/1993US5258504 Process for the purification of streptolysin O, intact streptolysin O obtainable by this process
11/02/1993US5258502 Immobilization and purification of fusion proteins using chitin-binding ability
11/02/1993US5258501 Stabilization of glycoproteins
11/02/1993US5258497 Process for purifying annexines
11/02/1993US5258496 Precipitation and extraction of proteins
11/02/1993US5258454 Solid phase synthesis of proteins with polystyrene grafted polymer substrate
10/1993
10/30/1993WO1993022682A1 In vitro test for helicobacter pylori
10/28/1993WO1993021303A2 Enhanced purification and expression of insoluble recombinant proteins
10/28/1993WO1993021224A1 Ultrapure human epidermal growth factor
10/28/1993WO1993021218A1 Synthetic polypeptides derived from the hiv envelope glycoprotein
10/28/1993WO1993021215A1 Peptides having tachykinin antagonist activity
10/28/1993WO1993021207A1 Process for making vancomycin
10/28/1993WO1993021206A1 Synthetic, stabilized, three-dimension polypeptides
10/28/1993CA2118503A1 Peptides having tachykinin antagonist activity
10/28/1993CA2118033A1 Synthetic polypeptides derived from the hiv envelope gylcoprotein
10/28/1993CA2118028A1 Ultrapure human epidermal growth factor
10/27/1993EP0567448A1 Factor VIII preparation
10/27/1993EP0567088A2 Processes for the preparation of amylase inhibitor
10/27/1993EP0566673A1 Biosynthetic pdgf antagonists
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/27/1993EP0431059B1 A method for carrying out organic chemical reactions and apparatus for carrying out that method
10/27/1993CN1077715A Process for simultaneous renaturation and purification of denatured protein
10/26/1993US5256769 Separating protein or its N-methionine analog from mixture utilizing difference in isoelectric points
10/26/1993US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
10/26/1993US5256294 Tangential flow filtration process and apparatus
10/26/1993CA1323728C Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody
10/26/1993CA1323727C Glutamine-containing peptides, a process for the preparation thereof, and the use thereof
10/26/1993CA1323726C Chromogenic compounds, a process for their preparation, and their use
10/26/1993CA1323567C Method for purification of antibodies
10/25/1993CA2094797A1 Method of treating and preventing viral infections using hbnf and mk protein
10/20/1993EP0566459A1 Reagent and catalytic process for cleaving protected functional groups
10/20/1993EP0566289A1 Analysis of hemoglobin variants by capillary electrophoresis
10/20/1993EP0566066A1 Antigens of human non-small lung carcinoma
10/20/1993EP0565607A1 Protection group, compoud protected by this group and device for grafting the protection group onto the compound being protected
10/20/1993EP0565590A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
10/20/1993EP0220241B1 Purified protein having angiogenic activity and methods of preparation
10/19/1993US5254673 Purification of zein from corn gluten meal
10/19/1993US5254672 Synthetic peptides which contain sequences from factor VIIa, and the use thereof
10/19/1993US5254476 Method and system for analysis of peptides and proteins
10/19/1993US5254475 Coupling to form a peptidylhydantoin derivative; cleaving
10/18/1993CA2091944A1 Analysis of hemoglobin variants by capillary zone electrophoresis
10/16/1993CA2093989A1 Reagent and catalytic process for clearing a protected function
10/14/1993WO1993020442A1 Reagents and methods for the detection and quantification of thyroxine in fluid samples
10/14/1993WO1993020208A1 Methods for producing substantially pure eg iii cellulase using polyethylene glycol
10/14/1993WO1993020100A1 Novel lipophilic oligopeptides with immunomodulating activity
10/14/1993WO1993020098A1 Process for preparing modified proteins
10/14/1993WO1993020079A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
10/14/1993WO1993020070A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
10/14/1993WO1993020064A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
10/14/1993WO1993020048A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
10/14/1993WO1993019785A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection
10/14/1993CA2133569A1 Novel lipophilic oligopeptides with immunomodulating activity
10/14/1993CA2132446A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
10/14/1993CA2132445A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
10/14/1993CA2132342A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
10/14/1993CA2132340A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivatives conjugates and labels
10/14/1993CA2131727A1 Reagents and methods for the detection and quantification of thyroxine in fluid samples
10/13/1993EP0565484A2 HIV-protease inhibiting morpholin- and thiomorpholin-4-ylamides
10/13/1993EP0565148A2 Intermediates for preparation of H-Arg-X-Y-Z-Tyr-R
10/13/1993EP0564739A2 Backbone cyclic peptides, processes for their preparation and pharmaceutical compositions containing them
10/13/1993EP0564587A1 Solution phase process for synthesis of peptide
10/13/1993EP0540687A4 Antibody-mediated cofactor-driven reactions
10/13/1993EP0233197B1 Water soluble xanthylium derivative substrates
10/13/1993CN1022412C Method for preparing urethane-protected amino acid-N-carboxyanhydrides
10/12/1993US5252719 Process for preparing protein-oriented membrane
10/12/1993US5252715 Process for the preparation of a pasteurized and iron-free human transferrin and the use thereof
10/12/1993US5252714 Preparation and use of polyethylene glycol propionaldehyde
10/12/1993US5252710 Selective chromatographic separation of Factor VIII from von Willebrand factor; desorption, purification
10/12/1993US5252709 Adjustment of ph of buffer
10/12/1993US5252708 Preparation process for a protein containing at least one intramolecular disulphide bridge by oxidation, at a pH of less than 5.0 of corresponding reduced recombinant protein
10/12/1993US5252560 Cyclic imide derivatives, compositions and use
10/12/1993US5252558 Pentapeptide having specific inhibiting effect on epidermal cell proliferation, the salts thereof, pharmaceutical compositions comprising the same and a process for the preparation of the pentapeptide and the pharmaceutical compositions
10/12/1993US5252296 Method and apparatus for biopolymer synthesis
10/12/1993US5252216 Using combination chromatography
10/11/1993CA2093575A1 Human antithrombin iii mutant
10/06/1993EP0563329A1 Angiogenic peptides
10/06/1993EP0563302A1 Method and apparatus for granulation
10/06/1993EP0563244A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
10/06/1993EP0563091A1 Vaccines based on hepatitis b surface antigen
10/05/1993US5250665 Specifically β-β cross-linked hemoglobins and method of preparation
10/05/1993US5250613 Solid surface coated with a hydrophilic outer layer with covalently bonded biopolymers, a method of making such a surface, and a conjugate therefor
10/05/1993US5250516 Forming protective layer of thermoelastic polypeptide
10/05/1993CA1322745C Porous wafer for segmented synthesis of biopolymers
10/02/1993CA2093109A1 Morpholin- and thiomorpholin-4-ylamides
10/02/1993CA2093099A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection